ELANE and prostate carcinoma: Nonetheless, increased protein expression of the NE enzyme, dopa decarboxylase (DDC; E.C. 4.1.1.28) correlates with castrate-resistant disease [21], further supporting a NE program associated with castrate-resistant prostate cancer.